Found: 36
Select item for more details and to access through your institution.
Targeting the Divergent Roles of STK3 Inhibits Breast Cancer Cell Growth and Opposes Doxorubicin-Induced Cardiotoxicity In Vitro.
- Published in:
- Cancers, 2023, v. 15, n. 10, p. 2817, doi. 10.3390/cancers15102817
- By:
- Publication type:
- Article
NEK Family Review and Correlations with Patient Survival Outcomes in Various Cancer Types.
- Published in:
- Cancers, 2023, v. 15, n. 7, p. 2067, doi. 10.3390/cancers15072067
- By:
- Publication type:
- Article
Covalent inhibitors of EGFR family protein kinases induce degradation of human Tribbles 2 (TRIB2) pseudokinase in cancer cells.
- Published in:
- Science Signaling, 2018, v. 11, n. 549, p. 1, doi. 10.1126/scisignal.aat7951
- By:
- Publication type:
- Article
Novel application of the published kinase inhibitor set to identify therapeutic targets and pathways in triple negative breast cancer subtypes.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0177802
- By:
- Publication type:
- Article
Progress towards a public chemogenomic set for protein kinases and a call for contributions.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0181585
- By:
- Publication type:
- Article
How many kinases are druggable? A review of our current understanding.
- Published in:
- Biochemical Journal, 2023, v. 480, n. 16, p. 1331, doi. 10.1042/BCJ20220217
- By:
- Publication type:
- Article
New tools for evaluating protein tyrosine sulfation: tyrosylprotein sulfotransferases (TPSTs) are novel targets for RAF protein kinase inhibitors.
- Published in:
- Biochemical Journal, 2018, v. 475, n. 15, p. 2435, doi. 10.1042/BCJ20180266
- By:
- Publication type:
- Article
New tools for carbohydrate sulfation analysis: heparan sulfate 2-O-sulfotransferase (HS2ST) is a target for small-molecule protein kinase inhibitors.
- Published in:
- Biochemical Journal, 2018, v. 475, n. 15, p. 2417, doi. 10.1042/BCJ20180265
- By:
- Publication type:
- Article
Donated chemical probes for open science.
- Published in:
- eLife, 2018, p. 1, doi. 10.7554/eLife.34311
- By:
- Publication type:
- Article
Quantifying CDK inhibitor selectivity in live cells.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-16559-0
- By:
- Publication type:
- Article
Strategic Fluorination to Achieve a Potent, Selective, Metabolically Stable, and Orally Bioavailable Inhibitor of CSNK2.
- Published in:
- Molecules, 2024, v. 29, n. 17, p. 4158, doi. 10.3390/molecules29174158
- By:
- Publication type:
- Article
Synthesis and Evaluation of Novel 1,2,6-Thiadiazinone Kinase Inhibitors as Potent Inhibitors of Solid Tumors.
- Published in:
- Molecules, 2021, v. 26, n. 19, p. 5911, doi. 10.3390/molecules26195911
- By:
- Publication type:
- Article
In Depth Analysis of Kinase Cross Screening Data to Identify CAMKK2 Inhibitory Scaffolds.
- Published in:
- Molecules, 2020, v. 25, n. 2, p. 325, doi. 10.3390/molecules25020325
- By:
- Publication type:
- Article
1,2,6-Thiadiazinones as Novel Narrow Spectrum Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CaMKK2) Inhibitors.
- Published in:
- Molecules, 2018, v. 23, n. 5, p. 1221, doi. 10.3390/molecules23051221
- By:
- Publication type:
- Article
Solid-supported reagents in organic synthesis.
- Published in:
- Medicinal Research Reviews, 1999, v. 19, n. 2, p. 97, doi. 10.1002/(SICI)1098-1128(199903)19:2<97::AID-MED2>3.0.CO;2-Y
- By:
- Publication type:
- Article
An open source plant kinase chemogenomics set.
- Published in:
- Plant Direct, 2022, v. 6, n. 11, p. 1, doi. 10.1002/pld3.460
- By:
- Publication type:
- Article
Binding and structural analyses of potent inhibitors of the human Ca<sup>2+</sup>/calmodulin dependent protein kinase kinase 2 (CAMKK2) identified from a collection of commercially-available kinase inhibitors.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-52795-1
- By:
- Publication type:
- Article
A public-private partnership to unlock the untargeted kinome.
- Published in:
- Nature Chemical Biology, 2012, v. 9, n. 1, p. 3, doi. 10.1038/nchembio.1113
- By:
- Publication type:
- Article
Application of a small molecule inhibitor screen approach to identify CXCR4 downstream signaling pathways that promote a mesenchymal and fulvestrant-resistant phenotype in breast cancer cells.
- Published in:
- Oncology Letters, 2021, v. 21, n. 5, p. N.PAG, doi. 10.3892/ol.2021.12641
- By:
- Publication type:
- Article
Salt-Inducible Kinase 1 is a potential therapeutic target in Desmoplastic Small Round Cell Tumor.
- Published in:
- Oncogenesis, 2022, v. 11, n. 1, p. 1, doi. 10.1038/s41389-022-00395-6
- By:
- Publication type:
- Article
Structure-Bioactivity Relationship for Benzimidazole Thiophene Inhibitors of Polo-Like Kinase 1 (PLK1), a Potential Drug Target in Schistosoma mansoni.
- Published in:
- PLoS Neglected Tropical Diseases, 2016, v. 10, n. 1, p. 1, doi. 10.1371/journal.pntd.0004356
- By:
- Publication type:
- Article
EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen.
- Published in:
- Journal of Pathology, 2016, v. 239, n. 3, p. 320, doi. 10.1002/path.4729
- By:
- Publication type:
- Article
Modulation of tau tubulin kinases (TTBK1 and TTBK2) impacts ciliogenesis.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-32854-4
- By:
- Publication type:
- Article
Profile of the GSK Published Protein Kinase Inhibitor Set Across ATP-Dependent and-Independent Luciferases: Implications for Reporter-Gene Assays.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0057888
- By:
- Publication type:
- Article
Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin-dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiology.
- Published in:
- eLife, 2023, p. 1, doi. 10.7554/eLife.88206
- By:
- Publication type:
- Article
NUAK family kinase 2 is a novel therapeutic target for prostate cancer.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 3, p. 334, doi. 10.1002/mc.23374
- By:
- Publication type:
- Article
NEK5 activity regulates the mesenchymal and migratory phenotype in breast cancer cells.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 1, p. 49, doi. 10.1007/s10549-021-06295-4
- By:
- Publication type:
- Article
CK2 Chemical Probes: Past, Present, and Future.
- Published in:
- Kinases & Phosphatases, 2023, v. 1, n. 4, p. 288, doi. 10.3390/kinasesphosphatases1040017
- By:
- Publication type:
- Article
Illumination of understudied ciliary kinases.
- Published in:
- Frontiers in Molecular Biosciences, 2024, p. 1, doi. 10.3389/fmolb.2024.1352781
- By:
- Publication type:
- Article
PKIS deep dive yields a chemical starting point for dark kinases and a cell active BRSK2 inhibitor.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-72869-9
- By:
- Publication type:
- Article
Synergistic drug combinations and machine learning for drug repurposing in chordoma.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-70026-w
- By:
- Publication type:
- Article
Identification of 4‐Anilinoquin(az)oline as a Cell‐Active Protein Kinase Novel 3 (PKN3) Inhibitor Chemotype**.
- Published in:
- ChemMedChem, 2022, v. 17, n. 12, p. 1, doi. 10.1002/cmdc.202200161
- By:
- Publication type:
- Article
Crystal Structure and Inhibitor Identifications Reveal Targeting Opportunity for the Atypical MAPK Kinase ERK3.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 21, p. 7953, doi. 10.3390/ijms21217953
- By:
- Publication type:
- Article
New Compound Sets Identified from High Throughput Phenotypic Screening Against Three Kinetoplastid Parasites: An Open Resource.
- Published in:
- Scientific Reports, 2015, p. 8771, doi. 10.1038/srep08771
- By:
- Publication type:
- Article
CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-10424-5
- By:
- Publication type:
- Article
E2F1 proteolysis via SCF‐cyclin F underlies synthetic lethality between cyclin F loss and Chk1 inhibition.
- Published in:
- EMBO Journal, 2019, v. 38, n. 20, p. 1, doi. 10.15252/embj.2018101443
- By:
- Publication type:
- Article